#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11678	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2016	567.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	686	C	675	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11678	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2016	567.8	0	HET	.	.	.	C207T,G	.	207	207	C	435	435	C	639	C,T,G	332,283,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11678	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2016	567.8	0	HET	.	.	.	C451T	.	451	451	C	679	679	C	652	C,T	505,133	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21602	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3534	605.6	0	.	n	.	0	T695C	SNP	695	695	T	1019	1019	C	659	C,T,G	625,19,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21602	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3534	605.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1962	1962	G	678	G,A	511,156	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21602	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3534	605.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2295	2295	C	618	C	604	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21602	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3534	605.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2369	2369	A	676	A	665	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21602	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3534	605.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2921	2921	C	626	C	612	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	1428	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1527	92.5	0	.	p	.	0	M180T	NONSYN	538	540	ATG	873	875	ACG	119;118;115	A;C,T;G	118;116,1;114	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1464	folP	855	855	100.0	folP.l15.c17.ctg.1	1580	91.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1135	1137	AGC	117;118;119	A;G;C	116;117;117	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3962	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3440	113.9	1	SNP	p	S91F	1	.	.	271	273	TTC	550	552	TTC	143;142;145	T;T;C	139;139;142	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3962	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3440	113.9	1	SNP	p	G95N	0	.	.	283	285	GGC	562	564	GGC	137;137;136	G;G;C	133;133;133	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3962	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3440	113.9	1	SNP	p	D95G	1	.	.	283	285	GGC	562	564	GGC	137;137;136	G;G;C	133;133;133	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1290	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1409	91.0	1	SNP	p	G45D	0	.	.	133	135	GGC	503	505	GGC	166;164;166	G;G;C	163;161;161	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	662	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	934	70.0	0	.	n	.	0	A197.	DEL	197	197	A	541	541	A	140	A	133	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2875	126.2	1	SNP	p	D86N	0	.	.	256	258	GAC	566	568	GAC	140;140;141	G;A;C	138;128;137	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2875	126.2	1	SNP	p	S87R	1	.	.	259	261	CGT	569	571	CGT	141;142;141	C,A;G;T	136,3;139;136	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2875	126.2	1	SNP	p	R87I	0	.	.	259	261	CGT	569	571	CGT	141;142;141	C,A;G;T	136,3;139;136	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2875	126.2	1	SNP	p	R87W	0	.	.	259	261	CGT	569	571	CGT	141;142;141	C,A;G;T	136,3;139;136	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2875	126.2	1	SNP	p	S88P	0	.	.	262	264	TCC	572	574	TCC	141;144;145	T;C;C,T	134;140;139,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3212	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2699	117.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1538	1540	GGC	154;150;152	G;G;C	151;146;144	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1262	1264	GCC	180;181;185	G;C;C,A	176;176;180,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1265	1267	ATG	183;183;184	A;T;G,C	179;178;174,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1277	1279	ACC	192;191;192	A,G;C,T;C,G	185,1;184,1;188,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1277	1279	ACC	192;191;192	A,G;C,T;C,G	185,1;184,1;188,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1778	1780	ACC	155;157;157	A,G;C;C,T	147,1;153;151,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1832	1834	GCG	143;150;148	G;C;G	140;148;142	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1832	1834	GCG	143;150;148	G;C;G	140;148;142	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1955	1957	GGT	122;121;118	G;G;T,C	118;116;110,4	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1964	1966	AGC	110;110;106	A,G;G,A;C	105,4;109,1;105	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	135.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1982	1984	CCG	88;89;90	C;C,A;G	84;85,1;85	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	321	92.86	penA.l15.c4.ctg.2	320	3.0	0	.	p	.	0	H201Y	NONSYN	601	603	CAT	65	67	TAT	2;2;2	T;A;T	2;2;2	.	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	321	92.86	penA.l15.c4.ctg.2	320	3.0	0	.	p	.	0	A202G	NONSYN	604	606	GCT	68	70	GGC	2;2;2	G;G;C	2;2;2	.	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	321	92.86	penA.l15.c4.ctg.2	320	3.0	0	.	p	.	0	G203E	NONSYN	607	609	GGA	71	73	GAA	2;2;2	G;A;A	2;2;2	.	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	321	92.86	penA.l15.c4.ctg.2	320	3.0	0	.	p	.	0	E204D	NONSYN	610	612	GAA	74	76	GAC	2;2;2	G;A;C	2;2;2	.	.
penA.34.001	penA.34.001	1	1	527	3322	penA	1746	321	92.86	penA.l15.c4.ctg.2	320	3.0	0	.	p	.	0	R271fs	FSHIFT	811	811	C	275	275	C	2	C	1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4312	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3145	136.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1665	1667	CCG	137;138;139	C;C,T;G	128;133,4;133	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	519	1730	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1871	91.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	624	624	C	120	C	116	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	1730	porA	1146	119	98.32	porA.l15.c4.ctg.2	118	0.0	0	.	p	.	0	V76G	NONSYN	226	228	GTG	64	66	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	1730	porA	1146	119	98.32	porA.l15.c4.ctg.2	118	0.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	84	84	C	ND	ND	ND	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2252	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1533	144.2	1	SNP	p	G120K	1	.	.	358	360	AAG	708	710	AAG	153;154;155	A,G;A,G;G,C	150,1;152,1;149,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2252	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1533	144.2	1	SNP	p	A121N	1	.	.	361	363	AAC	711	713	AAC	156;155;157	A,G;A,C;C	154,1;154,1;152	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2252	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1533	144.2	1	SNP	p	N121D	0	.	.	361	363	AAC	711	713	AAC	156;155;157	A,G;A,C;C	154,1;154,1;152	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7892	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4782	163.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	900	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1066	83.1	1	SNP	p	V57M	1	.	.	169	171	ATG	492	494	ATG	176;175;178	A;T;G	174;174;173	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
